Navigation Links
Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia
Date:6/29/2009

lly bioavailable agent might expand usage and improve patient compliance as well.

"This sooner than expected start of preclinical development studies is an affirmation of CrystalGenomics' capability to discover novel drug candidates in an efficient way and through shared responsibilities with Palkion, we will accelerate our drug development process and establish CG as a global-scale pharmaceutical firm," stated Dr. Joong-Myung Cho, President and CEO of CrystalGenomics.

"Excellent progress has been made in our collaboration with CrystalGenomics. We have now assembled an outstanding team to progress our lead candidate toward the clinic," stated Wendy Johnson, President and CEO of Palkion.

About Palkion: Palkion, Inc. is a private early stage company developing oral drugs to treat anemia based on discovery and development of oral agents that inhibit prolyl hydroxylase enzymes. The inhibition of these enzymes results in endogenous production of erythropoietin, leading to the production of red blood cells. The use of an oral agent provides convenience and dosing flexibility potentially reaching more patients than the current injectable products. The company was formed by ProQuest Investments and CrystalGenomics, Inc. in February 2008.

About CrystalGenomics: CrystalGenomics, Inc. is a novel drug discovery and development company with several developmental candidates in the areas of cancer, inflammation and novel antibiotics. The lead candidate, CG100649 is a next generation NSAID with high safety and efficacy, which recently completed phase IIa of 248 patients for osteoarthritis in Europe. CG200745 is an oral/IV HDAC inhibitor for cancer and CG400549 is a novel antibiotic against MRSA and VRSA, both of which are in pre-clinical studies in Europe. The company has competitive and proprietary platform technologies for structural biology, structure-based novel scaffold/lead design, lead optimization a
'/>"/>

SOURCE Palkion, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service
2. HybridSPE(TM)-Precipitation Technology Wins SelectScience.net 2009 Scientists Choice Award for Best New Separations Product in 2008
3. Gemin X Pharmaceuticals Selects and Deploys Clinical Force CTMS
4. The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
5. VeraSun Energy Selects Valero as Successful Bidder for Seven Facilities
6. USAID Selects Abt Associates to Lead Team in Strengthening Mexico Private Sector Competitiveness
7. The Australian Research Council Selects Scopus for the Evaluation of the Australian Research Landscape
8. Cleveland Clinic Selects Laparoendoscopic Single-Site Surgery (LESS) as One of the Top Ten Innovations of 2009
9. The IN VIVO Blog Selects First Annual Deal of the Year
10. Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians
11. WuXi AppTec Selects H-Cube from ThalesNano for Laboratory-based Hydrogenation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2013)... 2013  Stem cells have long been touted as the ... to Dr. Dennis Lox , some patients with a ... to stem cell therapy for aid. Avascular necrosis (AVN) also ... in which the blood supply to the bone becomes disrupted, ... to as necrosis. The region may be very painful, and ...
(Date:6/14/2013)... DIEGO , June 14, 2013  Mast Therapeutics, ... an underwritten public offering of 50,000,000 units, each unit ... common stock and one warrant to purchase 0.5 of ... price of $0.50 per unit.  The units will not ... stock and the warrants are immediately separable and will ...
(Date:6/14/2013)... Toronto, ON / Boston, MA (PRWEB) June 14, ... the world’s largest independent resource for life scientists ... new e-commerce features within the growing 1DegreeBio marketplace. ... quickly browse through hundreds of vendor catalogues, access ... create purchase orders, email products to lab managers ...
(Date:6/13/2013)... Eagle Biosciences is proud to announce ... Calprotectin ELISA assay kit that offers the ... µg/g stool). The Calprotectin ELISA assay kit is ... Calprotectin (neutrophil cytoplasmic protein s100A8/A9, MRP 8/14) in ... assay line which already includes Alpha 1 Antitrypsin ...
Breaking Biology Technology:Stem Cells May Help Some With Avascular Necrosis (AVN) 2Mast Therapeutics Prices Public Offering Of Units 2Mast Therapeutics Prices Public Offering Of Units 3Mast Therapeutics Prices Public Offering Of Units 41DegreeBio Inc. Boosts Review-Driven Reagent Marketplace with New e-Commerce Platform 2Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit 2
... Mass., May 9 Millstone Medical Outsourcing,announced ... ISO 13485,certified quality system to the Memphis, ... the world,s largest developer and,publisher of international ... a highly-experienced quality engineer, to serve as ...
... 9 The International Center for Adult,Stem ... that,it has officially launched a global communications ... Spinal Cord Injury Symposium,Olfactory Mucosa Autografts (OMA) ... through May 10th in Argostolli, Kefalonia, Greece. ...
... announced financial results for the first quarter 2008. Novavax,reported a ... the first,quarter of 2008 compared to a net loss of ... 2007. Total cash and short-term investments,as of March 31, 2008 ... 2007. The cash burn for the quarter was $5.6 million., ...
Cached Biology Technology:Millstone Medical Outsourcing Achieves Quality Advantages in Memphis: Certified ISO 13485, Hires Experienced Quality Manager 2International Center for Adult Stem Cell Education Debuts at Spinal Cord Injury Symposium in Greece 2Novavax Reports First Quarter 2008 Financial Results 2Novavax Reports First Quarter 2008 Financial Results 3Novavax Reports First Quarter 2008 Financial Results 4Novavax Reports First Quarter 2008 Financial Results 5Novavax Reports First Quarter 2008 Financial Results 6Novavax Reports First Quarter 2008 Financial Results 7Novavax Reports First Quarter 2008 Financial Results 8
(Date:6/14/2013)... will collaborate with researchers from Oklahoma State University, ... of Tulsa to advance understanding of how socio-ecological ... and variability in the state. , Oklahoma ... $20 million National Science Foundation Experimental Program to ... innovative research over the next five years. ...
(Date:6/14/2013)... work carried out by the Carbohydrate Metabolism Research ... jointly owned by the NUP/UPNA-Public University of Navarre, ... Government of Navarre), the discovery has been made ... (now renamed as the "surface composition regulator", scoR) ... in bacterial infection can be altered by manipulating ...
(Date:6/14/2013)... week in the journal Science , Swedish and ... million year old fossil fishes, revealed by unique fossils ... help scientists to understand how neck muscles and abdominal ... naturally conjures up a vision of rattling skeletons. Bones ... and are usually the only traces of the animal ...
Breaking Biology News(10 mins):OU researchers collaborate on $20 million NSF EPSCoR grant 2OU researchers collaborate on $20 million NSF EPSCoR grant 3Discovery of how a gene that regulates factors involved in bacteria pathogenicity acts 2Discovery of how a gene that regulates factors involved in bacteria pathogenicity acts 3
... This release is available in Spanish . ... oldest persons in the world, who recently died at the ... which could have contributed to this longevity. The research team, ... pointed out a healthy lifestyle, a Mediterranean diet, a temperate ...
... may have an important role to play in the fate ... recent war campaigns, according to a new report in the ... Press. The researchers found evidence that fungi can ... less likely to find its way into plants, animals, or ...
... plague may be more virulent than their close relatives because ... the May issue of the journal Microbiology. The plague ... body temperature. When there is no calcium available, it produces ... said Professor Brubaker from the University of Chicago, USA. We ...
Cached Biology News:The secret to long life may not be in the genes 2Fungi have a hand in depleted uranium's environmental fate 2
... Serum • Cyno serum is collected off the clot ... years of age. Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium Oxalate ... N-05: ACD N-07: CPD N-09: ...
All serum is collected from adult animals aged 6 months or older. Certified U.S. orgin. Pricing: $35/unit for 1 - 10 units...
adult...
DNA Purification...
Biology Products: